PlainRecalls
FDA Drug Low Class III Terminated

Adalat CC (nifedipine) Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 5242749401

Reported: April 12, 2017 Initiated: March 7, 2017 #D-0633-2017

Product Description

Adalat CC (nifedipine) Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 5242749401

Reason for Recall

Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Details

Recalling Firm
Alvogen, Inc
Units Affected
N/A
Distribution
Nationwide
Location
Pine Brook, NJ

Frequently Asked Questions

What product was recalled?
Adalat CC (nifedipine) Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 5242749401. Recalled by Alvogen, Inc. Units affected: N/A.
Why was this product recalled?
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Which agency issued this recall?
This recall was issued by the FDA Drug on April 12, 2017. Severity: Low. Recall number: D-0633-2017.